Taurine: a simple supplement to fight radiation mouth sores?

NCT ID NCT07567742

Not yet recruiting Symptom relief Sponsor: Sun Yat-sen University Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This phase 2 trial tests whether taking taurine (a common amino acid) can prevent or reduce severe mouth sores caused by radiation therapy in people with nasopharyngeal cancer. 130 patients will take taurine pills or receive standard care starting 3 days before radiation until 1 week after. The main goal is to see if fewer people get severe mouth sores with taurine.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: taurine
What this could lead to: If it works, this could offer a simple, low-cost way to reduce painful mouth sores during radiation therapy for nasopharyngeal cancer.
What could go wrong: This is a small, early-phase trial (130 people) and not yet recruiting. The open-label design means both patients and doctors know who gets taurine, which can bias results. Taurine may not reduce severe mouth sores more than standard care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NASOPHARYNGEAL CARCINOMA (NPC) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

nasopharyngeal carcinoma stomatitis ulcer disease ulcerative stomatitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NASOPHARYNGEAL CARCINOMA (NPC) ORAL MUCOSITIS (ULCERATIVE) DUE TO RADIATION

Contacts and locations

Locations

Sun Yat-sen University Cancer Center

Guangzhou, Guangdong, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.